Bill Sponsor
House Bill 6946
117th Congress(2021-2022)
SAFE Act of 2022
Introduced
Introduced
Introduced in House on Mar 7, 2022
Overview
Text
Introduced
Mar 7, 2022
Latest Action
Nov 1, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6946
Congress
117
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Democrat
New Hampshire
Democrat
Minnesota
Republican
Nebraska
Republican
New Jersey
Democrat
New York
Republican
North Carolina
Republican
Washington
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Save Americans from the Fentanyl Emergency Act of 2022 or the SAFE Act of 2022

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.

The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

Text (1)
March 7, 2022
Actions (4)
11/01/2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
03/08/2022
Referred to the Subcommittee on Health.
03/07/2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/07/2022
Introduced in House
Public Record
Record Updated
Aug 15, 2023 1:00:32 PM